Best therapists: TOP 162 doctors

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood
Abdullah Sakin
  • 5 Excellent 2 reviews
  • 18 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  •  

    Experience

    2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

     

    2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

     

    2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

     

    2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

     

    2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

     

    2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

     

    2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

     

    2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

     

    2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

     

    2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

     

    2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

     

    2008 - 2012 Haseki Training and Research Hospital

     

    2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

     

     

    Education

    2018

    İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

    2018

    İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

    2012

    İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

    2012

    İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

    2007

    Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

     

  • Read more
Umbilical cord stem cell therapy
$7,000 - $9,000
Info
Nail Paksoy
  • 5 Excellent 2 reviews
  • 14 years of experience
  • accreditation:
  • Turkey, Istanbul, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Read more
Umbilical cord stem cell therapy
$7,000 - $9,000
Info
Dursun Aras
  • 5 Excellent 2 reviews
  • 29 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  • Experience

    2019 - 2022

    University of Health Sciences, Faculty of Medicine, Ankara City Hospital, Cardiology Clinic, Ankara

    2017 - 2019

    University of Health Sciences, Faculty of Medicine, Turkey Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

    2012 - 2017

    Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

    2012 - 2017

    T.R. Karabük University, Faculty of Medicine, Department of Cardiology

    2006 - 2006

    Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

    2001 - 2006

    Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

    1996 - 2001

    Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic, Ankara,

     

    Education

    2017 Karabük University, Faculty of Medicine, Department of Cardiology

     

    2006 Türkiye Higher Specialization Training and Research Hospital, Cardiology Clinic

     

    2001 Türkiye Higher Specialization Training and Research Hospital, Ankara, Cardiology

     

    1996 Ankara University, Faculty of Medicine

  • Read more
Umbilical cord stem cell therapy
$7,000 - $9,000
Info
Omer Alyan
  • 5 Excellent 2 reviews
  • 27 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  • Experience

    2018 - 2022

    Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital

    2016 - 2018

    Diyarbakır Memorial Dicle Hospital Cardiology Clinic

    2010 - 2010

    Dicle University Faculty of Medicine, Department of Cardiology

    2010 - 2016

    Private Veni Vidi Hospital, Cardiology Clinic Supervisor

    2006 - 2010

    Dicle University Faculty of Medicine, Department of Cardiology

    2005 - 2006

    Urfa State Hospital

    1999 - 2005

    Turkey High Specialization Training and Research Hospital

    1998 - 1999

    Duruca Health Center

     

    Education

    2018

    Health Sciences University, Cardiology

    2010

    Dicle University, Department of Cardiology

    2005

    Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization

    1998

    Ege University, Faculty of Medicine

  • Read more
Umbilical cord stem cell therapy
$7,000 - $9,000
Info
Kadir Idin
  • 5 Excellent 2 reviews
  • 28 years of experience
  • Turkey, Istanbul, Medipol Bahçelievler Hospital
  • Experience

    2016 - 2022

    ISTANBUL MEDIPOL UNIVERSITY

    2010 - 2016

    BEZM-I ÂLEM FOUNDATION UNIVERSITY

    2010 - 2015

    Bezmialem Vakif University Faculty of Medicine

    2009 - 2010

    Bagcilar Training and Research Hospital

    2009 - 2010

    ISTANBUL BAGCILAR TRAINING AND RESEARCH HOSPITAL

    1997 - 2009

    ISTANBUL HASEKI TRAINING AND RESEARCH HOSPITAL

    1997 - 2009

    Haseki Training and Research Hospital

     

    Education

    2016

    BEZM-I ÂLEM FOUNDATION UNIVERSITY, DEPARTMENT OF ANESTHESIOLOGY AND REANIMATION

    1997

    Istanbul Haseki Training and Research Hospital, Anesthesiology and Reanimation

    1993

    ISTANBUL HASEKI TRAINING AND RESEARCH HOSPITAL, Medical Specialization

    1989

    Istanbul University, Faculty of Medicine

    1983

    ISTANBUL UNIVERSITY, CERRAHPAŞA FACULTY OF MEDICINE, FACULTY OF MEDICINE

  • Read more
Umbilical cord stem cell therapy
$7,000 - $9,000
Info
Yvan Torrente
  • New
  • 25 years of experience
  • Turkey, Istanbul, Advanced Bio-Gen
  • With more than 120 medical publications on stem cells in preeminent medical journals, Professor Yvan Torrente is considered one of the world’s best scientists in regenerative medicine, genetic engineering of stem cells and advanced gene therapies for degenerative diseases. Prof. Torrente is currently the director of the Neurology department of the “Policlinico” Hospital in Milan as well as the head of the cell laboratory for the advanced therapy medical products in Milan.


    In addition, Yvan is a professor in neurology at the University of Milan. Prof. Torrente is assisted by a team of highly trained and well-regarded doctors, biologists and researchers in the laboratory in Milan who provide external assistance and consultancy to our medical team. Specifically, over the years, Professor Torrente has helped our team to develop GMP compliant and high-quality safety standards in complex research projects, applying the same to medicinal and clinical products catered for specific uses.


    Professor Torrente is currently leading and supervising several clinical trials in Europe on stem cell use in human beings as well as other advanced therapy medical products. He also provides assistance and consultancy services to several other hospitals worldwide, especially in the U.S., Canada and the U.K. Finally, Yvan is a well-known speaker at prestigious events, seminars and symposiums worldwide.

  • Read more
Doctor's visit
Price on request
Info

Find out about the best doctors here

20 top ranked Therapy doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.

The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.

Top 5 Therapy doctors on Bookimed.com:

How to choose the best Therapy doctors in the world?

The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.

Famous Therapy doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.

What is the cost of a doctor's consultation?

The price for the consultation on Therapy varies between experts and depends on certain factors, such as:

  • the country of practicing
  • the clinical experience and reputation
  • the medical degree and educational background
  • the doctor’s workload
  • medical developments, proprietary techniques used, and awards, if any.

How to make an appointment with a chosen doctor?

To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.

We can help to find the right doctors for Therapy if you have any difficulties with a choice. Bookimed services are free for patients ♥

Where you go for medical treatment

Dr Snehal Kohale
  • New
  • 15 years of experience
  • India, Thane, Ova Fertility and Women Care
Doctor's visit
Price on request
Info
Burcin Mutlu
  • New
  • 7 years of experience
  • Turkey, Istanbul, Moodist Psychiatry and Neurology Hospital
Doctor's visit
Price on request
Info
Carly Lapin
  • New
  • 16 years of experience
  • United States of America, Chicago, Rise Up For Autism
Doctor's visit
Price on request
Info
Doctor Alp Sabuncu
  • New
  • 43 years of experience
  • Turkey, Istanbul, NATURAL CLINIC
Doctor's visit
Price on request
Info
Doctor Hasret Demirci
  • New
  • 8 years of experience
  • Turkey, Istanbul, NATURAL CLINIC
  • Dr. Hasret Demirci is a dentist specializing in operative surgery with academic competence.
  • Read more
Doctor's visit
Price on request
Info
Doctor Tugba Kabaagac
  • New
  • 15 years of experience
  • Turkey, Istanbul, NATURAL CLINIC
Doctor's visit
Price on request
Info
Doctor Tarik Pak
  • New
  • 11 years of experience
  • Turkey, Istanbul, NATURAL CLINIC
Doctor's visit
Price on request
Info
Doctor Burak Demir
  • New
  • 12 years of experience
  • Turkey, Istanbul, NATURAL CLINIC
  • Dr. Burak Demir is a dentist who started his professional career in 2022. He completed his education at Çukurova University, Department of Dentistry. He has participated in multiple congresses and workshops and holds various awards and memberships.
  • Read more
Doctor's visit
Price on request
Info
Omer Uslukaya
  • 4.4 Good 50 reviews
  • 23 years of experience
  • Turkey, Istanbul, Memorial Ataşehir Hospital
  • EXPERIENCE*

     

    2019 - Present, Istanbul/Istanbul/Turkey

    MEMORIAL ATAŞEHİR HOSPITAL

    General Surgeon

    2012 - 2019, Diyarbakır/Diyarbakır/Turkey

    DİCLE UNIVERSITY FACULTY OF MEDICINE

    General Surgeon

    2011 - 2012, Van/Van/Turkey

    VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

    General Surgeon

    2009 - 2011, Van/Van/Turkey

    HAKKARİ STATE HOSPITAL

    General Surgeon

    2004 - 2009, Van/Van/Turkey

    YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

    General Surgeon

    2002 - 2004, Van/Van/Turkey

    HACIBEKİR HEALTH CENTER

    General Practitioner

     

    *EDUCATION*

     

    2018 - 2019, Diyarbakır/Turkey

    Associate Professor

    2015, Ohio/USA

    OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

    Neck Dissection Training

    2012 - 2018, Diyarbakır/Turkey

    Assistant Professor

    1996 - 2002, Adana/Turkey

    ÇUKUROVA UNIVERSITY

    FACULTY OF MEDICINE - Medical Doctor Education

  • Read more
Doctor's visit
Price on request
Info
Didem Altay Gazi
  • 5 Excellent 6 reviews
  • 35 years of experience
  • Turkey, Istanbul, Liv Hospital Vadistanbul
  • Education: 

    İstanbul Pertevniyal Anatolian High School 

    Trakya University Faculty of Medicine 

    İstanbul Okmeydanı Training And Research Hospital Family Practice 

    Experience: 

    Liv Hospital Ulus 2021-  

    Acıbadem Fulya Hospital 

    Adıyaman Sincik District State Hospital 

    Okmeydanı Training and Research Hospital 

    İstanbul Gaziosmanpaşa Karlıtepe A.H.D, Bağlarbaşı A.H.D. and Pazariçi A.H.D

    Memberships: 

    Turkish Medical Association (Istanbul Chamber of Doctors) 

    TAHUD (Turkish Family Physicians Specialty Association)

  • Read more
Doctor's visit
Price on request
Info
Arzu Musayeva
  • New
  • 39 years of experience
  • Azerbaijan, Baku, Biological Medicine-Integrative Health Center Baku
  • DR. Arzu Musaeva

    Education: Azerbaijan Medical University.

    Specialization: therapist

    Working hours and days: weekdays 10:00-15:00.

    Training and membership:

    16.02-31.03.2000 thematic development of the cycle “Current issues of infectious diseases”.

    02.01-15.02.2001 thematic cycle “Clinical pharmacotherapy of internal diseases”.

    improvement.

    01-30.12.2005 thematic improvement in the course “Chronic renal failure”.

    22.11-27.12.2005 "Applied Homotoxicology" (56 hours) prof. Safihan Gasanov.

    26-30.01.2006 "Applied Homotoxicology" (36 hours) Dr. Klaus Kuestermann (Baden-Baden,

    Germany).

    12-24.11.2006 "Applied Homotoxicology" (48 hours) Doctor of Technical Sciences Elena Nekrasova

    23-28.04.2007 "Homeoisopathy" Dr. Burkhard Flechsig.

    28.05-02.06.2007 "Sanum Therapy" Dr. Anita Krake (Germany).

    13.12. 2008. “Microbiological Therapy” Doctor of Medical Sciences Michael Schreiber (Germany).

    14-18.03.2008 "Module B" Dr. Marion Krasnitzer-Geyer, Dr. med. Siddhartha Popat (Baden-

    Baden, Germany).

    20-22.06.2008. "Acupuncture and Homeosiniatry" Dr. med. Siddhartha Popat (Baden-Baden,

    Germany).

    27-29.11.2009. "Introduction to Homeosiniatry" Dr. med. Joachim Bandlow.

    02/16/2010. "Homotoxicology" Dr. Alta Smith.

    05-09.11.2010. Course "Applied Homotoxicology" (36 hours). Dr. med. Burkhard Flechsig, Dr. med.

    Joachim Bandlow.

    21-22. 01.2011. "Introduction to Isopathy and Sanum Therapy". Med. Thomas Rau.

    04.04.2011. "Microbiological Therapy" Dr. Kerstin Rasch, Dr. Volker Rusch.

    10.20.2013. "Traditional medicine with biological medicine in diseases of the endocrinological and lymphatic systems"

    "Sharing Methods" by Dr. Jurgen Frost.

    07.04-02.05.2014 "Azerbaijan State Medical Institute named after A.Aliyev"

    refresher course.

    11/12/2014. "Inflammation: A New Concept" by Dr. Alta Smith.

    10-11.04.2015. "Diabetes, Stress and Associated Diseases" Dr. med. Siddhartha Popat

    (Baden-Baden, Germany).

    12-16.05.2015. "Neurology, autoimmune diseases" Dr. of Medical Sciences Thomas Rau (Switzerland).

    05/28/2015. "Basics of acid-base balance" "Hormones and health" Dr. med. Burkhard

    Flechsig (Germany).

    10.21.2015. "Fundamentals of Oncology" by Dr. Gerhard Reiss (Germany).

    12/21/2015. "Mesotherapy" Dr. Alta Smith (Germany).

    01-03.04.2016. Dr. "Allergy, Inflammation, Stress". Bert Hannosset (Germany).

    05/28-29/2016 “Aesthetic Medicine” Dr. Tatiana Rivkina (Italy).

    06/13-14/2016 “Fibromyalgia, Gout, Psoriasis” Dr. med. Gerhard Reis (Germany).

    04-08.10.2016. "Mucosa Syndrome" Dr. Arturo Obirne (Colombia).

    21.10. 2016. "Microbiological Therapy" by Dr. Uwe Peters (Germany).

    31.10-01.11.2016. "Thyroid depletion syndrome" Dr. Gerhard Reiss (Germany).

    10-11.11.2017. "Microbiological therapy – the basis of regulation" Dr. Uwe Peters (Germany).

    12.2017. "Neurotherapy and Homotoxicology" Dr. med. Siddhartha Popat (Baden-Baden,

    Germany).

    2017. "Metabolic Syndrome" Dr. med. Annette Jaensch.

    2017. "Healthy Aging, Proven Remedies in Integrative Medicine", Dr. Ralf Ottmaier

    (Switzerland).

    14-20.05.2018. "From segment to barrier, nutrition and inflammation, vitamin C and diabetes", doctor.

    honey. Arturo Obirne (Colombia).

    15-17.11.2018 "Elimination Therapy Methods, Success in Old Age" Dr. Marion Krasnitzer-Geyer

    (Baden-Baden, Germany).

    04.2018. "Bioregulatory treatment of chronic infections" Dr.rer.nat. Petra Grüning.

    21-23.09.2018. "Possibilities of treating degenerative diseases using systemic bioregulatory medicine"

    Doctor med. Siddhartha Popat (Baden-Baden, Germany).

    01/25/2019. "Basics of mistletoe therapy with Helixor and its application in practice" Doctor of Medical Sciences Christfried

    Preussler (Germany).

    05/11/2019 “Mesotherapy” Dr. Nicoletta Frasca

    05/14/2019. "Sanum Therapy for Liver Diseases" by Dr. Dieter Sonntag

    06.04.2019. "Isn't fatigue the call of the liver?" Dr. Petra Grüning.

    14-19.10.2019. "Bioregulatory treatment of dermatological diseases". med. Arturo Obirne

    (Colombia).

    Based on the results of successful treatment of trophic ulcers of various origins with biological preparations

    Received the Hans-Heinrich Reckeweg Prize for clinical cases.

    Examinations and treatment performed:

    • Bioregulatory therapy of all therapeutic diseases.

    • Atherosclerosis, stenosis, occlusion of peripheral arteries.

    • Varicose veins, thrombophlebitis, thrombosis, lymphostasis of peripheral veins.

    • Peripheral nerve neuropathy.

    • Diabetic paw, osteoarthropathy, osteomyelitis.

    • Detoxification and bioregulation of blood glucose at the cellular level. Diabetes mellitus

    treatment and prevention of delayed complications in the lower extremities.

    • Gangrenous pyoderma.

    • Treatment of trophic ulcers.

  • Read more
Doctor's visit
Price on request
Info
Fedash-kirsanov Alexander Alexandrovich
  • 5 Excellent 3 reviews
  • 15 years of experience
  • Ukraine, Kyiv, Impuls Medical Center
Doctor's visit
Price on request
Info
Tsios Yuri Anatolievich
  • 5 Excellent 3 reviews
  • 21 years of experience
  • Ukraine, Kyiv, Impuls Medical Center
Doctor's visit
Price on request
Info
Opr Dr Mevlut Kalcik
  • New
  • 75 years of experience
  • Turkey, Istanbul, Elinda Clinic
  • Plastic Surgery: We offer plastic surgery services with our experienced surgeons using up-to-date techniques. We aim to achieve natural and aesthetic results by producing solutions specific to each individual's needs.

    Hair, Beard and Eyebrow Transplantation: We offer special solutions to those struggling with hair loss, sparse beard or eyebrow problems. Our expert team aims to achieve natural results that suit the person's facial features.

    Filling Applications: We safely perform filling applications used for facial rejuvenation and contouring with our expert aesthetic surgeons. With our approach that prioritizes naturalness, we help our customers achieve the look they want.

  • Read more
Doctor's visit
Price on request
Info
Choosing Right Doctor and Clinic: Insider Tips
When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, etc.
Review success rates
Choose doctors with solid experience in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm if they provide accommodation and transfers, and check the costs.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team